Literature DB >> 32016096

Considerations for AR-V7 testing in clinical routine practice.

Christof Bernemann1, Laura-Maria Krabbe1, Andres Jan Schrader1.   

Abstract

Year:  2019        PMID: 32016096      PMCID: PMC6976390          DOI: 10.21037/atm.2019.12.136

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  20 in total

1.  Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer.

Authors:  Christof Bernemann; Thomas J Schnoeller; Manuel Luedeke; Konrad Steinestel; Martin Boegemann; Andres J Schrader; Julie Steinestel
Journal:  Eur Urol       Date:  2016-07-26       Impact factor: 20.096

2.  Performance comparison of two androgen receptor splice variant 7 (AR-V7) detection methods.

Authors:  Christof Bernemann; Julie Steinestel; Verena Humberg; Martin Bögemann; Andres Jan Schrader; Jochen K Lennerz
Journal:  BJU Int       Date:  2018-02-14       Impact factor: 5.588

3.  Comparative Analysis of AR Variant AR-V567es mRNA Detection Systems Reveals Eminent Variability and Questions the Role as a Clinical Biomarker in Prostate Cancer.

Authors:  Christof Bernemann; Verena Humberg; Barbara Thielen; Julie Steinestel; Xin Chen; Stefan Duensing; Andres J Schrader; Martin Boegemann
Journal:  Clin Cancer Res       Date:  2019-04-16       Impact factor: 12.531

Review 4.  Androgen receptor antagonists in castration-resistant prostate cancer.

Authors:  Dana Rathkopf; Howard I Scher
Journal:  Cancer J       Date:  2013 Jan-Feb       Impact factor: 3.360

Review 5.  Treatment of Advanced Prostate Cancer-A Review of Current Therapies and Future Promise.

Authors:  Semini Sumanasuriya; Johann De Bono
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

6.  AR-V7 and treatment selection in advanced prostate cancer: are we there yet?

Authors:  Diogo A Bastos; Emmanuel S Antonarakis
Journal:  Precis Cancer Med       Date:  2018-09-18

7.  Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY.

Authors:  Scott T Tagawa; Emmanuel S Antonarakis; Ada Gjyrezi; Giuseppe Galletti; Seaho Kim; Daniel Worroll; John Stewart; Atef Zaher; Ted P Szatrowski; Karla V Ballman; Katsuhiro Kita; Shinsuke Tasaki; Yang Bai; Luigi Portella; Brian J Kirby; Fred Saad; Mario A Eisenberger; David M Nanus; Paraskevi Giannakakou
Journal:  Clin Cancer Res       Date:  2018-10-09       Impact factor: 12.531

8.  Integrative clinical genomics of advanced prostate cancer.

Authors:  Dan Robinson; Eliezer M Van Allen; Yi-Mi Wu; Nikolaus Schultz; Robert J Lonigro; Juan-Miguel Mosquera; Bruce Montgomery; Mary-Ellen Taplin; Colin C Pritchard; Gerhardt Attard; Himisha Beltran; Wassim Abida; Robert K Bradley; Jake Vinson; Xuhong Cao; Pankaj Vats; Lakshmi P Kunju; Maha Hussain; Felix Y Feng; Scott A Tomlins; Kathleen A Cooney; David C Smith; Christine Brennan; Javed Siddiqui; Rohit Mehra; Yu Chen; Dana E Rathkopf; Michael J Morris; Stephen B Solomon; Jeremy C Durack; Victor E Reuter; Anuradha Gopalan; Jianjiong Gao; Massimo Loda; Rosina T Lis; Michaela Bowden; Stephen P Balk; Glenn Gaviola; Carrie Sougnez; Manaswi Gupta; Evan Y Yu; Elahe A Mostaghel; Heather H Cheng; Hyojeong Mulcahy; Lawrence D True; Stephen R Plymate; Heidi Dvinge; Roberta Ferraldeschi; Penny Flohr; Susana Miranda; Zafeiris Zafeiriou; Nina Tunariu; Joaquin Mateo; Raquel Perez-Lopez; Francesca Demichelis; Brian D Robinson; Marc Schiffman; David M Nanus; Scott T Tagawa; Alexandros Sigaras; Kenneth W Eng; Olivier Elemento; Andrea Sboner; Elisabeth I Heath; Howard I Scher; Kenneth J Pienta; Philip Kantoff; Johann S de Bono; Mark A Rubin; Peter S Nelson; Levi A Garraway; Charles L Sawyers; Arul M Chinnaiyan
Journal:  Cell       Date:  2015-05-21       Impact factor: 41.582

9.  Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.

Authors:  Andrew J Armstrong; Susan Halabi; Jun Luo; David M Nanus; Paraskevi Giannakakou; Russell Z Szmulewitz; Daniel C Danila; Patrick Healy; Monika Anand; Colin J Rothwell; Julia Rasmussen; Blair Thornburg; William R Berry; Rhonda S Wilder; Changxue Lu; Yan Chen; John L Silberstein; Gabor Kemeny; Giuseppe Galletti; Jason A Somarelli; Santosh Gupta; Simon G Gregory; Howard I Scher; Ryan Dittamore; Scott T Tagawa; Emmanuel S Antonarakis; Daniel J George
Journal:  J Clin Oncol       Date:  2019-03-13       Impact factor: 44.544

10.  Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer.

Authors:  Howard I Scher; David Lu; Nicole A Schreiber; Jessica Louw; Ryon P Graf; Hebert A Vargas; Ann Johnson; Adam Jendrisak; Richard Bambury; Daniel Danila; Brigit McLaughlin; Justin Wahl; Stephanie B Greene; Glenn Heller; Dena Marrinucci; Martin Fleisher; Ryan Dittamore
Journal:  JAMA Oncol       Date:  2016-11-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.